CoChat

Hepcidin and Host Defense against Infectious Diseases

Open access

The DOI matches its Crossref record; 102 of the 103 references it cites were found in a registry or an index; 43 of the 198 sources its claims cite were checked for support.

Abstract

Hepcidin is the master regulator of iron homeostasis in vertebrates. The synthesis of hepcidin is induced by systemic iron levels and by inflammatory stimuli. While the role of hepcidin in iron regulation is well established, its contribution to host defense is emerging as complex and multifaceted. In this review, we summarize the literature on the role of hepcidin as a mediator of antimicrobial immunity. Hepcidin induction during infection causes depletion of extracellular iron, which is thought to be a general defense mechanism against many infections by withholding iron from invading pathogens. Conversely, by promoting iron sequestration in macrophages, hepcidin may be detrimental to cellular defense against certain intracellular infections, although critical in vivo studies are needed to confirm this concept. It is not yet clear whether hepcidin exerts any iron-independent effects on host defenses.

Overview

CoChat Summary

TL;DR

Hepcidin is the master regulator of vertebrate iron homeostasis and is induced by inflammation, but its role in host defense is complex: iron restriction appears protective in some extracellular infections while macrophage iron sequestration may be detrimental in intracellular infections. The review concludes that direct antimicrobial effects of hepcidin in vivo are unlikely and that many roles, especially iron-independent ones, remain speculative.

Key findings

  • Hepcidin induction during infection lowers extracellular iron and sequesters iron in macrophages by binding ferroportin and promoting its degradation; this “nutritional immunity” is protective in at least some extracellular bacterial infections, such as *Vibrio vulnificus*, where hepcidin-deficient mice are much more susceptible and hepcidin agonists restore protection.
  • In intracellular infections, in vitro data suggest hepcidin-mediated iron accumulation in macrophages may benefit pathogens such as *Salmonella* Typhimurium, *Mycobacterium tuberculosis*, *M. avium*, *Leishmania amazonensis*, *Chlamydia*, and *Legionella*, but in vivo data are conflicting or unaddressed.
  • In malaria, hepcidin has complex effects: it likely contributes to anemia but may protect mice by reducing iron availability to parasites; in hepatitis C, HCV suppresses hepcidin expression, contributing to iron overload and disease pathology.
  • A direct microbicidal role for hepcidin in mammalian infections is unlikely because serum hepcidin concentrations are 1–2 orders of magnitude lower than those required for antimicrobial effects in vitro. The paper also notes that the common HFE C282Y mutation has a heterozygous prevalence of up to 10% in northern European populations, and that standard mouse chow contains 150–300 ppm iron versus approximately 35 ppm for an iron-sufficient diet.

Methods

  • Narrative literature review summarizing published in vitro, animal-model, and human studies on hepcidin in infectious diseases.
  • No primary experiments or new data are reported; evidence is synthesized qualitatively and summarized in Table 1 by infection location, pathogen, purported hepcidin role, and quality of evidence.
  • The review covers intracellular infections, siderophilic bacterial infections, sepsis, malaria, viral infections including HCV and HIV, and proposed iron-independent functions.

Limitations

  • The paper states that critical in vivo studies are needed to confirm whether hepcidin-mediated macrophage iron sequestration is detrimental in intracellular infections, and that any iron-independent role of hepcidin in host defense remains speculative.
  • The paper states that the role of hepcidin remains undefined in most infections, with little evidence for a direct microbicidal role in vivo and limited investigation in viral, fungal, and most parasitic infections.
  • Evident from the text: this is a narrative review without a systematic search or meta-analysis, and the authors note that in vivo studies are conflicting and that extrapolating from Hfe-deficient mice to hepcidin function is not straightforward because hepcidin expression is only attenuated, not abrogated, in those animals.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1004998

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 Overview of host iron homeostasis. Iron is absorbed from the diet by duodenal enterocytes and transported into the bloodstream, where it is bound by transferrin. Most iron is incorporated into erythrocytes for heme synthesis. Splenic macrophages recover iron from senescent erythrocytes and release iron into circulation via ferroportin. Smaller amounts of iron are imported into other tissues as needed. Iron loss is not directly regulated and occurs through minor bleeding and shedding of duodenal enterocytes. Approximate iron content of adult human tissues is represented in parentheses.
Fig 1 Overview of host iron homeostasis. Iron is absorbed from the diet by duodenal enterocytes and transported into the bloodstream, where it is bound by transferrin. Most iron is incorporated into erythrocytes for heme synthesis. Splenic macrophages recover iron from senescent erythrocytes and release iron into circulation via ferroportin. Smaller amounts of iron are imported into other tissues as needed. Iron loss is not directly regulated and occurs through minor bleeding and shedding of duodenal enterocytes. Approximate iron content of adult human tissues is represented in parentheses.CC BY · PubMed Central
Fig 2 The effect of hepcidin on iron homeostasis. In the absence of hepcidin, iron absorbed from the diet by duodenal enterocytes is transported into the serum via ferroportin, and iron captured from senescent red blood cells is exported from splenic macrophages. In the presence of hepcidin, iron is retained in duodenal enterocytes, which eventually shed from the intestinal tract, blocking iron absorption from the diet. Mononuclear phagocytes retain and accumulate recycled iron rather than releasing it back into circulation, causing a drop in serum iron levels.
Fig 2 The effect of hepcidin on iron homeostasis. In the absence of hepcidin, iron absorbed from the diet by duodenal enterocytes is transported into the serum via ferroportin, and iron captured from senescent red blood cells is exported from splenic macrophages. In the presence of hepcidin, iron is retained in duodenal enterocytes, which eventually shed from the intestinal tract, blocking iron absorption from the diet. Mononuclear phagocytes retain and accumulate recycled iron rather than releasing it back into circulation, causing a drop in serum iron levels.CC BY · PubMed Central
Fig 3 Mechanisms of hepcidin induction. In hepatocytes, hepcidin induction is mediated primarily by BMP ligands binding with the HJV/BMPR complex. BMP6 is induced by high iron levels via an undefined mechanism. The protease TMPRSS6 inhibits hepcidin production by degrading HJV in response to low iron levels [95]. High holo-transferrin levels stabilize the transferrin receptor 2 (Tfr2)/HFE complex, which promotes hepcidin induction, possibly by direct binding with HJV or BMPR [100]. Hepcidin can also be induced by IL-6 via STAT3 signaling in hepatocytes and myeloid leukocytes. Inflammation can stimulate hepcidin production in myeloid leukocytes through pathogen recognition receptor signaling and through autocrine and paracrine production of IL-6.
Fig 3 Mechanisms of hepcidin induction. In hepatocytes, hepcidin induction is mediated primarily by BMP ligands binding with the HJV/BMPR complex. BMP6 is induced by high iron levels via an undefined mechanism. The protease TMPRSS6 inhibits hepcidin production by degrading HJV in response to low iron levels [95]. High holo-transferrin levels stabilize the transferrin receptor 2 (Tfr2)/HFE complex, which promotes hepcidin induction, possibly by direct binding with HJV or BMPR [100]. Hepcidin can also be induced by IL-6 via STAT3 signaling in hepatocytes and myeloid leukocytes. Inflammation can stimulate hepcidin production in myeloid leukocytes through pathogen recognition receptor signaling and through autocrine and paracrine production of IL-6.CC BY · PubMed Central

Verification

Claims the paper makes

10 Valid · 4 Not valid · 42 Not checked · 9 Own results and interpretations

41 more claims · 7 with their cited sources checked

Create a free account to see all 65 claims and to verify the 155 references still open.

See all claims — free account
  • It may state two separate claims as one. 16
  • Probably not a substantial claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 102 references

Cited by

See all 207

Metadata

Authors
Michels, K., Nemeth, E., Ganz, T., & Mehrad, B.
Affiliations
  • University of Virginia (US)
  • University of California, Los Angeles (US)
Corresponding author
Mehrad, Borna
Venue
PLOS Pathogens
Published
2015-08-20
Volume
11
Issue
8
Pages
e1004998
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W1141274631
Cited by
205
References
103
Citations by year
2026: 6 · 2025: 13 · 2024: 13 · 2023: 16 · 2022: 21 · 2021: 28 · 2020: 23 · 2019: 20 · 2018: 27 · 2017: 23 · 2016: 14 · 2015: 1
FWCI
3.24
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL098526, HL098526, R01HL098329, HL098329)
  • National Institute of Allergy and Infectious Diseases (AI117397, R21AI117397, T32AI007046)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK090554, R01DK107309, DK090554)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
Keywords
hepcidin, iron homeostasis, host defense, antimicrobial immunity, iron sequestration, macrophages, intracellular infection, inflammation, iron depletion, infectious diseases
MeSH terms
Animals, Communicable Diseases, Humans, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepcidin and Host Defense against Infectious Diseases. https://app.cochat.ai/papers/10.1371/journal.ppat.1004998
The paper
Michels, K., Nemeth, E., Ganz, T., & Mehrad, B. (2015). Hepcidin and Host Defense against Infectious Diseases. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1004998

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.